Summary
This prediction ended on 26.08.24 with a price of €27.90. With a performance of 2.95%, the BUY prediction by ExpenseLiquidity38 for Bayer AG closed with a slight gain. ExpenseLiquidity38 has 50% into this predictionBayer is a multinational pharmaceutical and life sciences company headquartered in Germany. The company was founded in 1863 and has since grown to become a global leader in the fields of pharmaceuticals, agriculture, and consumer health. Bayer is listed on the Frankfurt Stock Exchange and also trades over-the-counter in the United States under the ticker symbol BAYZF. The company's products include prescription drugs, over-the-counter medicines, and agrochemicals, and it operates in more than 90 countries around the world.
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Bayer AG | -0.757% | -0.757% | 114.396% |
| iShares Core DAX® | -0.821% | -2.027% | 9.725% |
| iShares Nasdaq 100 | -1.743% | -5.354% | -0.863% |
| iShares Nikkei 225® | 1.215% | 6.383% | 27.786% |
| iShares S&P 500 | -1.167% | -3.462% | 0.098% |
Comments by ExpenseLiquidity38 for this prediction
In the thread Trading Bayer AG
Die von ExpenseLiquidity38 gewählte maximale Laufzeit wurde überschritten